Analysis of TCGA data showed that the highest frequency of AMBRA1 genetic alterations occurred in uterine corpus endometrial carcinoma, melanoma, and STAD, with missense mutations being the primary alteration type (Supplementary Figure S1). This evidence concerns the gene AMBRA1 and gastric adenocarcinoma.